Advanced Solid Tumor Historically Known for High EphA2 Expression

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Advanced Solid Tumor Historically Known for High EphA2 Expression trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Active — Not RecruitingPhase 1/2

NCT04180371

Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression

This clinical trial is evaluating a drug called BT5528 alone and in combination with nivolumab in participants with advanced solid tumors historically known for…

United States288 participantsStarted 2019-11-07

Treatment: BT5528, Nivolumab